Sandra Lin, Author at MedicalAdvancesToday

5 min 0

A phase 1 clinical study showed a small molecule drug targeting lipoprotein (a) can reduce its level by 65%

Sandra Lin
August 29, 2023

This phase I clinical trial demonstrated that oral administration of Muvalaplin was effective in lowering lipoprotein(a) levels without serious side effects.

9 min 0

Scientists have discovered a novel target for Alzheimer’s Disease and the clinical results are astounding

Sandra Lin
June 5, 2023

TB006 could easily dissolve these disease-causing Gal-3 proteins, and after 36 days of treatment, 25.4% of patients achieved a response, significantly better than placebo.

4 min 0

Scientists uncovered the key function of mitochondria in cancer cells, providing new strategies for cancer treatment

Sandra Lin
March 23, 2023

This study revealed that the nutritional preference of lung cancer cells may be determined by the subcellular compartmentation of their mitochondria and other organelles.

6 min 0

Diagnostics

Researchers confirmed that cfDNA methylation sequencing is of great value for early cancer screening

Sandra Lin
March 20, 2023

A circulating free DNA (cfDNA) methylation detection technology is able to sensitively screen 6 common cancers and significantly reduce the occurrence of advanced cancers.

7 min 0

China’s Renji Hospital discovers the key molecular mechanism of pancreatic cancer liver metastasis

Sandra Lin
March 19, 2023

This study found that the interaction between ROBO1 expressed on the tumor surface and the ligand SLIT2 derived from liver cells promotes the liver metastasis of pancreatic cancer.

4 min 0

Innovative Tech

Researchers successfully developed a culture system for long-term expansion of human hematopoietic stem cells in vitro

Sandra Lin
March 18, 2023

This newly established system uses an optimal chemically defined cell culture medium, thereby providing a suitable alternative to systems using typical cytokine-containing media in vitro.

Author: Sandra Lin

A phase 1 clinical study showed a small molecule drug targeting lipoprotein (a) can reduce its level by 65%

Scientists have discovered a novel target for Alzheimer’s Disease and the clinical results are astounding

Scientists uncovered the key function of mitochondria in cancer cells, providing new strategies for cancer treatment

Researchers confirmed that cfDNA methylation sequencing is of great value for early cancer screening

China’s Renji Hospital discovers the key molecular mechanism of pancreatic cancer liver metastasis

Researchers successfully developed a culture system for long-term expansion of human hematopoietic stem cells in vitro

Healthy gut bacteria can help fight cancer elsewhere in the body

Only one mRNA vaccine shot can reduce HPV-related tumors, and the effect is better than DNA or recombinant protein vaccines

A 10-year follow-up study of nearly 13,000 people found that regular vitamin D supplementation reduces the risk of dementia by 40%

Researchers revealed the B cell mechanism of autoimmunity triggered by the clearance of susceptible macrophages in lymph nodes

A phase 1 clinical study showed a small molecule drug targeting lipoprotein (a) can reduce its level by 65%

For the first time in 20 years, FDA fully approved a new drug for Alzheimer’s disease

Scientists have discovered a novel target for Alzheimer’s Disease and the clinical results are astounding

Simufilam, an investigational oral drug for Alzheimer’s Disease, improved cognition in 47% of treated patients in a Phase 2 study

A phase 1 clinical study showed a small molecule drug targeting lipoprotein (a) can reduce its level by 65%

Scientists have discovered a novel target for Alzheimer’s Disease and the clinical results are astounding

Simufilam, an investigational oral drug for Alzheimer’s Disease, improved cognition in 47% of treated patients in a Phase 2 study